Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADME Study of [14C]-Etamicastat in Healthy Male Subjects
NCT03014375Phase 1Completed
- Sponsor
- BIAL
- Start
- Sep 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of etamicastat in hypertension (HTN) and heart failure (HF), sponsored by BIAL. Primary endpoints: Urinary excretion of BIA 5-453 associated radioactivity, Faecal excretion of BIA 5-453 associated radioactivity and 1 more. Started Sep 2008; status: completed.
02
Drugs
etamicastat
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT03014375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03014375.